Blog Posts - U.s



Nike (NKE) and Jabil Circuit (JBL) Surpass Estimates; Bellerophon (BLPH) Soars on Study Data

Nike, Inc. (NKE) Shares of NKE climbed to touch an all-time high in after-hours trading Thursday as the company delivered stronger-than-expected quarterly profit and revenue in its financial reults For its first quarter fiscal 2016, NKE posted revenu...
by CRWE-PR Finance on Sep 24, 2015

China’s Effect On The Global Economy

China’s economy has seen double digit growth for the last 3 decades.. In 1979, the changes to China’s economy was due to a reform labeled as “market-oriented” . New policies were created. Because of this the ownership of land was given to...
by NZ Home Business on Sep 12, 2015

Rakyat Amerika peringati serangan 9/11 atau 11 September 2001

Alfido.com | News... Jika sampeyan ingin membaca artikel Alfido.com lebih lanjut, silakan klik link judul diatas atau kunjungi langsung di http://alfido.com :). Thanks...
by Alfido.com on Sep 10, 2015

NovaBay (NBY) Solid Business Momentum; Palo Alto Networks (PANW) Surpasses Estimates

 NovaBay Pharmaceuticals, Inc. (NBY) NBY‘sPresident and CEO Ron Najafi, Ph.D., will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Thursday, September 10, 2015 at 3:25 p.m. Eastern time (12:25 p.m. Pacific time...
by CRWE-PR Finance on Sep 10, 2015

Oshkosh (OSK) Inks Mega-Deal; Dycom (DY) Exceeds Forecasts; Sequenom (SQNM) Liquid Biopsy Momentum

Oshkosh Corp. (OSK) After the closing bell on Tuesday, OSK said that the U.S. Army Tank-automotive and Armaments Command Life Cycle Management Command has awarded OSK‘s Oshkosh Defense a $6.7 billion firm fixed price production contract to manu...
by CRWE-PR Finance on Aug 26, 2015

NW Bio Confirms Phase III Trial of DCVax®-L for GBM Brain Cancer Is Ongoing

BETHESDA, MD / CRWEPRESSRELEASE/ August 21, 2015 – Northwest Biotherapeutics (NASDAQ: NWBO) (“NW Bio”), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, confirmed today that its Phase III t...
by CRWE-PR Finance on Aug 23, 2015

BB&T Corp. (BBT) Posts Solid Results, Declares Common Stock Dividend

BB&T Corporation (BBT) BBT recently delivered solid quarterly results, led by improved loan growth and strong credit quality. For the second quarter 2015, BBT posted revenues of $2.37 billion, a 1.3% increase year over year, and net income of $45...
by CRWE-PR Finance on Jul 21, 2015

BP to Settle Federal, State and Local Deepwater Horizon Claims for up to $18.7 Billion With Payments to be Spread Over 18 Years

London, UK / CRWEPRESSRELEASE / July 2, 2015 / The Disclosure and Transparency Rules (“DTR”) made by the Financial Conduct Authority govern amongst other matters the disclosure of inside information. Accordingly in compliance with Rule 2.2, BP pl...
by CRWE-PR Finance on Jul 2, 2015

MeetMe (MEET) Boosts Outlook; Goldman Sachs Sees Potential In Ford Motor (F)

MeetMe, Inc. (MEET) Shares of MEET soared more than 20% in extended-hours trading Tuesday after the company boosted its quarterly guidance for revenue and adjusted EBITDA, based on progress it has made in successfully transitioning management of its...
by CRWE-PR Finance on Jun 24, 2015

FDA Approves Brain Implant to Help Reduce Parkinson’s Disease and Essential Tremor Symptoms

Las Vegas, NV / CRWEPRESSRELEASE / June 12, 2015 / The U.S. Food and Drug Administration today approved the Brio Neurostimulation System, an implantable deep brain stimulation device to help reduce the symptoms of Parkinson’s disease and essential...
by CRWE-PR Finance on Jun 12, 2015

GW Pharmaceuticals Initiates Second Phase 3 Pivotal Study of Epidiolex(R) (CBD) in Lennox-Gastaut Syndrome

London, UK / CRWEPRESSRELEASE / 11 June 2015 / GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics fr...
by CRWE-PR Finance on Jun 11, 2015

Retrophin (RTRX) At All-Time High Levels on RE-024 FDA-Status, Syneron (ELOS) Settles Legal Battle

Retrophin, Inc. (RTRX) Shares of RTRX touched an all-time high in after-hours trading Thursday as the company said that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its novel investigational phosphopantothenate r...
by CRWE-PR Finance on Jun 5, 2015

G-III Apparel (GIII) and Ambarella (AMBA) Beat Consensus; Insider Bets on Heron Therapeutics (HRTX)

G-III Apparel Group, Ltd. (GIII) Shares of GIII surged to reach a new 52-week high in after-hours trading Tuesday as the company delivered quarterly profit and revenue above Wall Street analysts’ expectations. For its first quarter fiscal 2016,...
by CRWE-PR Finance on Jun 3, 2015

June 1, 2015 Weekly Market Strategies

Covering High return Balanced Investing Strategies To Make Money In Up Or Down Markets A Publication of Princeton Research, Inc. (www.PrincetonResearch.com) Contributing Staff: Michael King, Charles Moskowitz June 1, 2015 Market Strategies Guide to S...
by CRWE-PR Finance on May 31, 2015

Heron Therapeutics (HRTX) Momentum on Top-Line Study Results; Is Rosetta Stone (RST) a Takeover Target?

Heron Therapeutics, Inc. (HRTX) Shares of HRTX soared to reach a record high in extended-hours trading Thursday after the company reported positive, top-line results from its recently completed Phase 3 MAGIC study. According to HRTX, its 5-HT3 recept...
by CRWE-PR Finance on May 29, 2015

Kevin Douglas Bets on EnteroMedics (ETRM); Popeyes (PLKI) and AMERCO (UHAL) Top Estimates

EnteroMedics Inc. (ETRM) Kevin Douglas, an active securities and commodities investor, disclosed on Wednesday in a regulatory filing ( SC 13D ) with the Securities and Exchange Commission (SEC) a 14.2% stake in ETRM (10,951,705 shares). ETRM reported...
by CRWE-PR Finance on May 28, 2015

Omnicare (OCR) At All-Time High Levels On Potential Buyout, Glenview Capital Raises Stake In Monsanto (MON)

Omnicare Inc. (OCR) Shares of OCR surged to reach a record high in after-hours trading Wednesday, following a report by Bloomberg indicating that drugstore operator CVS Health Corp. (CVS) is in advanced takeover talks with the company. OCR recently...
by CRWE-PR Finance on May 21, 2015

SAPIEN 3 Valve Again Demonstrates Low Mortality, Excellent 30-Day Outcomes In Intermediate-Risk Patients

PARIS / CRWEPRESSRELEASE / May 20, 2015 / Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that 30-day outcomes for intermediate-risk patients treated transfem...
by CRWE-PR Finance on May 20, 2015

Momo (MOMO) Profitability Momentum; Apple (AAPL) Feeling Icahn’s Touch

Momo Inc. (MOMO) Shares of MOMO soared significantly in after-hours trading Monday as the company delivered strong topline growth in its quarterly financial results, achieving profitability for the first time in its operating history For the first qu...
by CRWE-PR Finance on May 19, 2015

Crown Equity Holdings Inc (CRWE) Provides Business Update

Crown Equity Holdings Inc. (CRWE) The company is currently developing its CRWE Network ( www.CRWE-PR.com ), a growing network of community targeted sites. CRWE Network‘s business model is based on selling advertising to businesses targeting bot...
by CRWE-PR Finance on May 19, 2015


Trending Topics

Close